RNAi News GenomeWeb News Premium Content Existing subscribers login here. New to RNAi News? For a trial subscription click here.

Startup Cequent Jumps Onto RNAi Drugs Field
With $6M VC Funding and Novel Delivery Tech

[January 25, 2007]

By Doug Macron

After securing $6 million in venture capital funding late last year, Cequent is aiming to file an IND on its first RNAi-based therapeutic, a treatment for familial adenomatous polyposis, by the second quarter of 2008.

Login | Subscribe